Information Journal Paper
APA:
Copy. (2019). Oncoprotein HBXIP induces PKM2 via transcription factor E2F1 to promote cell proliferation in ER-positive breast cancer. ACTA PHARMACOLOGY SINICA, 40(4), 530-358. SID. https://sid.ir/paper/725640/en
Vancouver:
Copy. Oncoprotein HBXIP induces PKM2 via transcription factor E2F1 to promote cell proliferation in ER-positive breast cancer. ACTA PHARMACOLOGY SINICA[Internet]. 2019;40(4):530-358. Available from: https://sid.ir/paper/725640/en
IEEE:
Copy, “Oncoprotein HBXIP induces PKM2 via transcription factor E2F1 to promote cell proliferation in ER-positive breast cancer,” ACTA PHARMACOLOGY SINICA, vol. 40, no. 4, pp. 530–358, 2019, [Online]. Available: https://sid.ir/paper/725640/en